医学
心脏病
重症监护医学
介绍
疾病
干预(咨询)
心脏病学
内科学
精神科
家庭医学
作者
Mary T. Donofrio,Anita J. Moon‐Grady,Lisa K. Hornberger,Joshua A. Copel,Mark Sklansky,Alfred Abuhamad,Bettina F. Cuneo,James C. Huhta,Richard A. Jonas,Anita Krishnan,Stephanie Lacey,Wesley Lee,Erik Michelfelder,Gwen R. Rempel,Norman H. Silverman,Thomas L. Spray,Janette F. Strasburger,Wayne Tworetzky,Jack Rychik
出处
期刊:Circulation
[Lippincott Williams & Wilkins]
日期:2014-04-25
卷期号:129 (21): 2183-2242
被引量:1205
标识
DOI:10.1161/01.cir.0000437597.44550.5d
摘要
Fetal cardiac medicine has evolved considerably over the past 2 decades, predominantly in response to advances in imaging technology and innovations in therapies. The diagnosis of cardiac disease in the fetus is mostly made with ultrasound; however, new technologies, including 3- and 4-dimensional echocardiography, magnetic resonance imaging, and fetal electrocardiography and magnetocardiography, are available. Medical and interventional treatments for select diseases and strategies for delivery room care enable stabilization of high-risk fetuses and contribute to improved outcomes. This statement highlights what is currently known and recommended on the basis of evidence and experience in the rapidly advancing and highly specialized field of fetal cardiac care.
科研通智能强力驱动
Strongly Powered by AbleSci AI